Overview

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase IV trial to investigate the effect of the combination of Letrozole with trastuzumab in metastatic breast cancer patients
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Collaborator:
Roche - Prof. Dr. Jens Huober et al.
Treatments:
Letrozole
Trastuzumab